News
Feeling bullish over FDA changes, Regenxbio solidifies filing plans for Duchenne gene therapy
5+ hour, 13+ min ago (15+ words) First Word Pharma...
Symbols: nasdaq:rgnx
Base-editing biotech launches straight onto NASDAQ in reverse merger with Boundless
1+ day, 9+ hour ago (14+ words) First Word Pharma...
Symbols: btc-usd
Biopharma bites: Remix's reverse merger, Absci's raise, ADC's layoffs, and a new R&D head for Lundbeck
7+ hour, 8+ min ago (18+ words) First Word Pharma...
Symbols: nyse:lly,btc-usd,nyse:abbv,nyse:pfe
FDA clears Pfizer's Ibrance for 'double positive' breast cancer
5+ hour, 13+ min ago (11+ words) First Word Pharma...
Symbols: nasdaq:bctx,tsx:bct
Vedana debuts with $46 M and a team of veterans to become 'the migraine company"
1+ week, 21+ hour ago (16+ words) Vedana debuts with $46 M and a team of veterans to become 'the migraine company' First Word Pharma...
Symbols: btc-usd,nasdaq:vrca
Physician Views Preview: Can Intellia's lonvo-z turn CRISPR promise into HAE practice?
1+ week, 1+ day ago (15+ words) First Word Pharma...
Symbols: nasdaq:crsp
Biopharma bites: Moderna welcomes ex-BMS, Novartis exec, plus heart benefits from COVID-19 shots
1+ week, 1+ day ago (17+ words) First Word Pharma...
Symbols: nasdaq:mrna
Verge Labs builds 'virtual biopsy' to cut neurology trial failure rates
1+ week, 1+ day ago (13+ words) First Word Pharma...
Symbols: btc-usd
FDA flags 'evidence gaps' for Moderna's m RNA flu shot, but no 'major' concerns
1+ week, 1+ day ago (15+ words) First Word Pharma...
Symbols: nasdaq:mrna
Moderna ticks up despite FDA flagging 'evidence gaps' for m RNA flu shot
1+ week, 1+ day ago (14+ words) First Word Pharma...
Symbols: nasdaq:mrna